Ankita Saikia

Title: Ankita Saikia: Innovator in Recombinant Human Insulin Crystallization

Introduction

Ankita Saikia is a prominent inventor based in Sivasagar, India. She has made significant contributions to the field of biochemistry, particularly in the crystallization of recombinant human insulin. Her innovative methods have the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.

Latest Patents

Ankita holds a patent for her invention titled "Preparative crystallization of recombinant human insulin." This patent discloses a method for crystallizing recombinant human insulin at both lab and manufacturing scales. The process involves the use of a mixture of zinc chloride and sodium chloride, along with a higher concentration of organic solvent (IPA-19 to 25 million). Additionally, the pH is adjusted to 5.0 at a faster rate (≤5 minutes). The method also includes procedures that reduce settling time and alter holding temperature to facilitate consistent protein crystal formation between 15 μm-30 μm, thereby increasing the robustness of the process.

Career Highlights

Ankita is currently employed at Biocon Limited, a leading biopharmaceutical company. Her work focuses on developing innovative solutions for insulin production, which is vital for patients with diabetes. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

Ankita has collaborated with notable colleagues, including Sandeep Vishwanath Kamath and Sethumadhavan Sankaran. These collaborations have further enriched her research and contributed to the advancement of biopharmaceutical technologies.

Conclusion

Ankita Saikia's contributions to the field of recombinant human insulin crystallization exemplify her innovative spirit and commitment to improving healthcare solutions. Her work not only enhances the production process but also holds promise for better diabetes management in the future.